Literature DB >> 12075820

Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin.

Hossein Hosseinkhani1, Teruyoshi Aoyama, Osamu Ogawa, Yasuhiko Tabata.   

Abstract

In vitro transfection efficiency of a plasmid DNA for rat gastric mucosal (RGM)-1 cells was enhanced by ultrasound (US) irradiation. Ethylenediamine was introduced to the carboxyl groups of gelatin to prepare a cationized gelatin as the vector of plasmid DNA encoding luciferase. An electrophoresis experiment revealed that the cationized gelatin was mixed with plasmid DNA at the weight ratio of 5.0 to form a cationized gelatin-plasmid DNA complex. The complex obtained was about 200nm in diameter with a positive charge. When incubated with the cationized gelatin-plasmid DNA complex and subsequently exposed to US, RGM-1 cells exhibited a significantly enhanced luciferase activity although the extent increased with an increase in the DNA concentration, in contrast to the cationized gelatin alone with or without US irradiation and US irradiation alone. US irradiation was also effective in enhancing the activity by free plasmid DNA although the extent was less than that of the complex. The US-induced enhancement of luciferase activity was influenced by the exposure time period, frequency, and intensity of US. The activity enhancement became higher to be significant at the irradiation time period of 60 s and thereafter decreased. A series of cytotoxicity experiments revealed that an increase in the irradiation time period and intensity of US decreased the viability of cells themselves. It is possible that US irradiation under an appropriate condition enables cells to accelerate the permeation of the cationized gelatin-plasmid DNA complex through the cell membrane, resulted in enhanced transfection efficiency of plasmid DNA. These findings clearly indicate that US exposure is a simple and promising method to enhance the gene expression of plasmid DNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075820     DOI: 10.1080/10611860290022624

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  8 in total

1.  Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.

Authors:  Rammohan Devulapally; Taehwa Lee; Aarohi Barghava-Shah; Thillai V Sekar; Kira Foygel; Sunitha V Bachawal; Jürgen K Willmann; Ramasamy Paulmurugan
Journal:  Nanomedicine (Lond)       Date:  2018-05-23       Impact factor: 5.307

2.  In vitro transfection of plasmid DNA by amine derivatives of gelatin accompanied with ultrasound irradiation.

Authors:  Hossein Hosseinkhani; Ternyoshi Aoyama; Shingo Yamamoto; Osamu Ogawa; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  Ultrasound for molecular imaging and therapy in cancer.

Authors:  Osamu F Kaneko; Jürgen K Willmann
Journal:  Quant Imaging Med Surg       Date:  2012-06

Review 4.  Micelles and nanoparticles for ultrasonic drug and gene delivery.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  Adv Drug Deliv Rev       Date:  2008-04-04       Impact factor: 15.470

5.  PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors.

Authors:  Marxa Figueiredo; Rinat Esenaliev
Journal:  J Drug Deliv       Date:  2012-02-28

6.  Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.

Authors:  Hitoshi Fujii; Akifumi Matsuyama; Hiroshi Komoda; Masao Sasai; Minoru Suzuki; Tomoyuki Asano; Yuichiro Doki; Mitsunori Kirihata; Koji Ono; Yasuhiko Tabata; Yasufumi Kaneda; Yoshiki Sawa; Chun Man Lee
Journal:  Radiat Oncol       Date:  2011-01-20       Impact factor: 3.481

7.  Porphyrin-magnetite nanoconjugates for biological imaging.

Authors:  Małgorzata Nowostawska; Serena A Corr; Stephen J Byrne; Jennifer Conroy; Yuri Volkov; Yurii K Gun'ko
Journal:  J Nanobiotechnology       Date:  2011-04-08       Impact factor: 10.435

8.  Cetuximab-siRNA Conjugate Linked Through Cationized Gelatin Knocks Down KRAS G12C Mutation in NSCLC Sensitizing the Cells Toward Gefitinib.

Authors:  K Sreedurgalakshmi; R Srikar; K Harikrishnan; Lakshmi Srinivasan; Reena Rajkumari
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.